刘振华, 刘银姬, 牛津, 贾敏, 付锋, 裴建明, 樊荣. U50,488H抑制心肌细胞缺氧/复氧诱导Drp1线粒体转位的作用及机制[J]. 心脏杂志, 2020, 32(6): 565-571. DOI: 10.12125/j.chj.202010053
    引用本文: 刘振华, 刘银姬, 牛津, 贾敏, 付锋, 裴建明, 樊荣. U50,488H抑制心肌细胞缺氧/复氧诱导Drp1线粒体转位的作用及机制[J]. 心脏杂志, 2020, 32(6): 565-571. DOI: 10.12125/j.chj.202010053
    Zhen-hua LIU, Yin-ji LIU, Jin NIU, Min JIA, Feng FU, Jian-ming PEI, Rong FAN. Effect of U50,488H on Drp1 mitochondria translocation in cardiomyocytes subjected to hypoxia/reoxygenation and its mechanism[J]. Chinese Heart Journal, 2020, 32(6): 565-571. DOI: 10.12125/j.chj.202010053
    Citation: Zhen-hua LIU, Yin-ji LIU, Jin NIU, Min JIA, Feng FU, Jian-ming PEI, Rong FAN. Effect of U50,488H on Drp1 mitochondria translocation in cardiomyocytes subjected to hypoxia/reoxygenation and its mechanism[J]. Chinese Heart Journal, 2020, 32(6): 565-571. DOI: 10.12125/j.chj.202010053

    U50,488H抑制心肌细胞缺氧/复氧诱导Drp1线粒体转位的作用及机制

    Effect of U50,488H on Drp1 mitochondria translocation in cardiomyocytes subjected to hypoxia/reoxygenation and its mechanism

    • 摘要:
        目的  研究κ-阿片受体(κ-OR)激动剂U50,488H对缺氧/复氧(H/R)原代心肌细胞Drp1线粒体转位的作用与机制。
        方法  将心肌细胞共分为6组,分别为常氧(Control)组、H/R组、H/R+U50,488H组、Control+Scramble RNAi组、H/R+Scramble RNAi组、H/R+Mid51 RNAi组。利用CCK-8试剂盒检测细胞活力;AnnexinV、PI试剂盒检测细胞凋亡;采用激光共聚焦显微镜观察线粒体的形态变化和Drp1与线粒体共定位情况,Western blotting检测细胞内线粒体外膜Drp1相关结合蛋白(Fis1、Mff、Mid49和Mid51)的表达水平。
        结果  与常氧组相比,H/R组细胞凋亡与死亡率明显增加(P<0.01),线粒体分裂明显增加(P<0.01),Drp1的线粒体转位明显增多,Mid51表达显著上调(P<0.01),但Fis1、Mff与Mid49的表达无明显差异;而κ-OR激动剂U50,488H可降低H/R后细胞凋亡与死亡率(P<0.01),抑制线粒体分裂(P<0.01),减少Drp1与线粒体的结合同时下调Mid51的表达水平(P<0.01),但Fis1、Mff与Mid49的表达无明显变化;进一步研究发现,敲低Mid51可降低H/R后细胞凋亡与死亡率(P<0.01,P<0.05),抑制线粒体的分裂(P<0.01),减少Drp1的线粒体的转位。
        结论  H/R可引起线粒体分裂与心肌细胞损伤,激活κ-OR可通过下调Mid51抑制Drp1的线粒体转位,进而抑制线粒体分裂,从而减轻H/R损伤。

       

      Abstract:
        AIM  To examine the effect and mechanism of κ-opioid receptor (κ-OR) activation by U50,488H on Drp1 mitochondria translocation in primary cardiomyocytes subjected to hypoxia/ reoxygenation (H/R).
        METHODS  Cardiomyocytes were divided into 6 groups: Control group, H/R group, H/R+U50,488H group, control+Scramble RNAi group, H/R+Scramble RNAi group, and H/R+Mid51 RNAi group. Cell viability was measured by CCK-8 detecting kit. Cell apoptosis was determined by flow cytometry. Mitochondria morphology and the colocalization of Drp1 and mitochondria were observed by laser confocal microscope. Western blotting was used to examine the Drp1-related protein’s expression levels of Fis1, Mff, Mid49 and Mid51.
        RESULTS  Compared with the control group, cell apoptosis, cell death and mitochondrial fission increased significantly in the H/R group (P<0.01). In addition, the amount of Drp1 translocated to mitochondrial surface and Mid51 were significantly increased (P<0.01) in the H/R group, while no significant changes were found in the expression of Fis1, Mff and Mid49. κ-OR stimulation by U50,488H reduced cell apoptosis and death rate (P<0.01), inhibited mitochondrial fission (P<0.01), reduced the colocalization level of Drp1 and mitochondria, and downregulated the expression of Mid51 (P<0.01). There were no significant changes in the expression of Fis1, Mff and Mid49 in the H/R group. Knockdown of Mid51 with small interfering RNA decreased the apoptosis and death rate (P<0.01, P<0.05), inhibited the mitochondrial fission (P<0.01) and reduced the mitochondrial translocation of Drp1.
        CONCLUSION  H/R triggers cardiomyocyte injury and increases mitochondrial fission. Activation of κ-OR by U50,488H reduces Drp1 translocation to mitochondria by inhibiting Mid51, and suppresses the abnormal mitochondrial dynamics induced by H/R, so as to alleviates cell injury.

       

    /

    返回文章
    返回